Dishman Carbogen Amcis Limited (DCAL) - Total Liabilities
Based on the latest financial reports, Dishman Carbogen Amcis Limited (DCAL) has total liabilities worth Rs47.44 Billion INR (≈ $513.07 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Dishman Carbogen Amcis Limited (DCAL) cash flow conversion to assess how effectively this company generates cash.
Dishman Carbogen Amcis Limited - Total Liabilities Trend (2005–2025)
This chart illustrates how Dishman Carbogen Amcis Limited's total liabilities have evolved over time, based on quarterly financial data. Check DCAL cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Dishman Carbogen Amcis Limited Competitors by Total Liabilities
The table below lists competitors of Dishman Carbogen Amcis Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GP-Act III Acquisition Corp. Class A Ordinary Share
NASDAQ:GPAT
|
USA | $14.67 Million |
|
Centurion Acquisition Corp.
NASDAQ:ALF
|
USA | $13.75 Million |
|
Sky Harbour Group Corp
NYSE MKT:SKYH
|
USA | $357.28 Million |
|
Viva Wine Group AB
ST:VIVA
|
Sweden | Skr3.15 Billion |
|
Wabash National Corporation
NYSE:WNC
|
USA | $802.70 Million |
|
Crawford & Company
NYSE:CRD-A
|
USA | $592.87 Million |
|
Feedback Technology
TWO:8091
|
Taiwan | NT$1.39 Billion |
|
Molson Coors Canada Inc
TO:TPX-B
|
Canada | CA$12.20 Billion |
Liability Composition Analysis (2005–2025)
This chart breaks down Dishman Carbogen Amcis Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Dishman Carbogen Amcis Limited market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.28 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dishman Carbogen Amcis Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dishman Carbogen Amcis Limited (2005–2025)
The table below shows the annual total liabilities of Dishman Carbogen Amcis Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs41.68 Billion ≈ $450.71 Million |
+5.41% |
| 2024-03-31 | Rs39.54 Billion ≈ $427.60 Million |
+8.51% |
| 2023-03-31 | Rs36.44 Billion ≈ $394.07 Million |
+17.98% |
| 2022-03-31 | Rs30.89 Billion ≈ $334.01 Million |
+15.79% |
| 2021-03-31 | Rs26.67 Billion ≈ $288.46 Million |
+7.35% |
| 2020-03-31 | Rs24.85 Billion ≈ $268.72 Million |
+27.46% |
| 2019-03-31 | Rs19.49 Billion ≈ $210.82 Million |
-5.79% |
| 2018-03-31 | Rs20.69 Billion ≈ $223.77 Million |
+16.28% |
| 2017-03-31 | Rs17.79 Billion ≈ $192.44 Million |
+16.42% |
| 2016-03-31 | Rs15.29 Billion ≈ $165.31 Million |
-2.71% |
| 2015-03-31 | Rs15.71 Billion ≈ $169.91 Million |
+14.10% |
| 2014-03-31 | Rs13.77 Billion ≈ $148.92 Million |
+9.26% |
| 2013-03-31 | Rs12.60 Billion ≈ $136.30 Million |
-4.53% |
| 2012-03-31 | Rs13.20 Billion ≈ $142.77 Million |
+9.72% |
| 2011-03-31 | Rs12.03 Billion ≈ $130.11 Million |
+19.35% |
| 2010-03-31 | Rs10.08 Billion ≈ $109.02 Million |
+2.37% |
| 2009-03-31 | Rs9.85 Billion ≈ $106.50 Million |
+9.89% |
| 2008-03-31 | Rs8.96 Billion ≈ $96.92 Million |
+6.32% |
| 2007-03-31 | Rs8.43 Billion ≈ $91.16 Million |
+107.07% |
| 2006-03-31 | Rs4.07 Billion ≈ $44.02 Million |
+132.48% |
| 2005-03-31 | Rs1.75 Billion ≈ $18.94 Million |
-- |
About Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organop… Read more